Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases.
Yi ZouLinying ChenXingfu WangYupeng ChenLiwen HuSaifan ZengPengcheng WangGuoping LiMing HuangLiting WangShi HeSanyan LiLihui JianSheng ZhangPublished in: Journal of gastric cancer (2019)
GC with ≥10% NED should be classified as a distinct subtype because of its worse prognosis, and more attention should be paid to the necessity of additional therapeutics for NE components.